The extracellular entrance provides selectivity to serotonin 5-HT7 receptor antagonists with antidepressant-like behavior in vivo.

The finding that ergotamine binds serotonin receptors in a less conserved extended binding pocket close to the extracellular entrance, in addition to the orthosteric site, allowed us to obtain 5-HT7R antagonist 6 endowed with high affinity (Ki=0.7 nM) and significant 5-HT1AR selectivity (ratio>1428). Compound 6 exhibits in vivo antidepressant-like effect (1 mg/kg, ip) mediated by the 5-HT7R, which reveals its interest as a putative research tool or pharmaceutical in depression disorders.

[1]  S. Henriksen,et al.  5-HT7 Receptor Inhibition and Inactivation Induce Antidepressantlike Behavior and Sleep Pattern , 2005, Biological Psychiatry.

[2]  P. Bonaventure,et al.  Translational Evaluation of JNJ-18038683, a 5-Hydroxytryptamine Type 7 Receptor Antagonist, on Rapid Eye Movement Sleep and in Major Depressive Disorder , 2012, Journal of Pharmacology and Experimental Therapeutics.

[3]  A. Sali,et al.  Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.

[4]  G. Haegeman,et al.  Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives , 2011, Molecular Neurobiology.

[5]  A. Wesołowska,et al.  Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. , 2006, European journal of pharmacology.

[6]  P. Bonaventure,et al.  8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. , 2004, European journal of pharmacology.

[7]  D. Zamanillo,et al.  Potentiation of morphine analgesia by adjuvant activation of 5-HT7 receptors. , 2011, Journal of pharmacological sciences.

[8]  J. Schwartz,et al.  Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  L. Pardo,et al.  Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives. , 2003, Journal of medicinal chemistry.

[10]  H. Manji,et al.  G protein-coupled receptors in major psychiatric disorders. , 2007, Biochimica et biophysica acta.

[11]  P. Blier,et al.  Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy , 2011, Neuropsychopharmacology.

[12]  A. Wesołowska,et al.  Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice. , 2007, European journal of pharmacology.

[13]  G. Simig,et al.  Optimization of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT₇ receptor antagonist activity. , 2011, Journal of medicinal chemistry.

[14]  A. Roberts,et al.  The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior , 2010, Behavioural Brain Research.

[15]  R. Stevens,et al.  Structural Features for Functional Selectivity at Serotonin Receptors , 2013, Science.

[16]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[17]  J. Sutcliffe,et al.  Functional, molecular and pharmacological advances in 5-HT7 receptor research. , 2004, Trends in pharmacological sciences.

[18]  V. Pittalà,et al.  Latest advances towards the discovery of 5-HT(7) receptor ligands. , 2011, Mini reviews in medicinal chemistry.

[19]  P. Whiting,et al.  Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression , 2005, Neuropharmacology.

[20]  A. Roberts,et al.  The 5‐HT7 receptor in learning and memory , 2012, Hippocampus.

[21]  Gianluigi Caltabiano,et al.  Impact of Helix Irregularities on Sequence Alignment and Homology Modeling of G Protein‐Coupled Receptors , 2012, Chembiochem : a European journal of chemical biology.

[22]  F. Nicoletti,et al.  Novel benzo[b]thiophene derivatives as new potential antidepressants with rapid onset of action. , 2011, Journal of medicinal chemistry.

[23]  L. Pardo,et al.  Serotonin 5-HT7 Receptor Antagonists , 2004 .

[24]  G. Haegeman,et al.  The serotonin 5-HT7 receptors: two decades of research , 2013, Experimental Brain Research.

[25]  D. Zamanillo,et al.  Role of peripheral versus spinal 5‐HT7 receptors in the modulation of pain undersensitizing conditions , 2012, European journal of pain.

[26]  E. Lacivita,et al.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. , 2011, Pharmacology & therapeutics.

[27]  Leonardo Pardo,et al.  Molecular Basis of Ligand Dissociation in β-Adrenergic Receptors , 2011, PloS one.

[28]  J. Plassat,et al.  Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. , 1993, Molecular pharmacology.

[29]  M. Botta,et al.  3D QSAR models of interactions between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA): a survey on taxanes and epothilones. , 2004, Current topics in medicinal chemistry.

[30]  Bryan L. Roth,et al.  Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo , 2009, Psychopharmacology.

[31]  A. Wesołowska,et al.  Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression , 2006, Neuropharmacology.

[32]  Jessica Sallander,et al.  Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. , 2009, Journal of medicinal chemistry.

[33]  A. Gasbarri,et al.  5-HT7 receptors in the modulation of cognitive processes , 2008, Behavioural Brain Research.

[34]  L. Salerno,et al.  5-HT7 receptor ligands: recent developments and potential therapeutic applications. , 2007, Mini reviews in medicinal chemistry.

[35]  P. Hedlund.  The 5-HT7 receptor and disorders of the nervous system: an overview , 2009, Psychopharmacology.

[36]  A. Roberts,et al.  Effects of lurasidone in behavioral models of depression. Role of the 5-HT7 receptor subtype , 2013, Neuropharmacology.

[37]  Hualiang Jiang,et al.  Structural Basis for Molecular Recognition at Serotonin Receptors , 2013, Science.

[38]  M. Babu,et al.  Molecular signatures of G-protein-coupled receptors , 2013, Nature.

[39]  Gianluigi Caltabiano,et al.  Membrane Protein Simulations Using AMBER Force Field and Berger Lipid Parameters. , 2012, Journal of chemical theory and computation.